Surgical approach to combined mitral and tricuspid valve disease: good neighbourhood rules
Key result
Prophylactic tricuspid annuloplasty during mitral surgery increases high-grade AV block and permanent pacemaker risk.
Why the study?
Tricuspid regurgitation commonly coexists with mitral valve disease and negatively impacts outcomes, but the optimal surgical approach and timing remain uncertain.
Population
Patients with combined mitral and tricuspid valve disease
Comparison
Combined surgical treatment versus transcatheter alternatives
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Combined mitral-tricuspid surgery merits consideration in degenerative cases with annular dilation despite added pacemaker risk; leaves open optimal transcatheter sequencing for functional disease.
Structured PICO
P
Population
Patients with combined mitral and tricuspid valve disease (degenerative or functional)
I
Intervention
Combined surgical treatment (tricuspid annuloplasty) or transcatheter alternatives
Combined surgical treatment of mitral and tricuspid valve disease requires a tailored, multidisciplinary approach, balancing the benefits of prophylactic tricuspid annuloplasty against the increased risk of pacemaker implantation.
Cite This Study
Ascione et al. (2022) conducted a review in Combined mitral and tricuspid valve disease. Combined surgical or transcatheter treatment was evaluated. Prophylactic tricuspid annuloplasty during degenerative mitral valve surgery is effective but increases the risk of high-grade atrio-ventricular blocks and the need for a definitive pacemaker.